Stryker's First Interventional Oncology Technology
The addition of the OptaBlate technology to Stryker’s Interventional Spine (IVS) portfolio expands on its core competencies in vertebral augmentation and radio-frequency ablation and completes its portfolio of treatment options for metastatic vertebral body fractures. As Stryker’s first Interventional Oncology technology, OptaBlate optimizes all aspects of the procedure—from set-up to ablation